1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Gastrointestinal Syndromic Multiplex Diagnostic
1.2.3 Central Nervous System Syndromic Multiplex Diagnostic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Syndromic Multiplex Diagnostic Market Perspective (2017-2028)
2.2 Syndromic Multiplex Diagnostic Growth Trends by Region
2.2.1 Syndromic Multiplex Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Syndromic Multiplex Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Syndromic Multiplex Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Syndromic Multiplex Diagnostic Market Dynamics
2.3.1 Syndromic Multiplex Diagnostic Industry Trends
2.3.2 Syndromic Multiplex Diagnostic Market Drivers
2.3.3 Syndromic Multiplex Diagnostic Market Challenges
2.3.4 Syndromic Multiplex Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue
3.1.1 Global Top Syndromic Multiplex Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Syndromic Multiplex Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Syndromic Multiplex Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Syndromic Multiplex Diagnostic Revenue
3.4 Global Syndromic Multiplex Diagnostic Market Concentration Ratio
3.4.1 Global Syndromic Multiplex Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Syndromic Multiplex Diagnostic Revenue in 2021
3.5 Syndromic Multiplex Diagnostic Key Players Head office and Area Served
3.6 Key Players Syndromic Multiplex Diagnostic Product Solution and Service
3.7 Date of Enter into Syndromic Multiplex Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Syndromic Multiplex Diagnostic Breakdown Data by Type
4.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2023-2028)
5 Syndromic Multiplex Diagnostic Breakdown Data by Application
5.1 Global Syndromic Multiplex Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Syndromic Multiplex Diagnostic Market Size (2017-2028)
6.2 North America Syndromic Multiplex Diagnostic Market Size by Type
6.2.1 North America Syndromic Multiplex Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Syndromic Multiplex Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Syndromic Multiplex Diagnostic Market Share by Type (2017-2028)
6.3 North America Syndromic Multiplex Diagnostic Market Size by Application
6.3.1 North America Syndromic Multiplex Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Syndromic Multiplex Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Syndromic Multiplex Diagnostic Market Share by Application (2017-2028)
6.4 North America Syndromic Multiplex Diagnostic Market Size by Country
6.4.1 North America Syndromic Multiplex Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Syndromic Multiplex Diagnostic Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Syndromic Multiplex Diagnostic Market Size (2017-2028)
7.2 Europe Syndromic Multiplex Diagnostic Market Size by Type
7.2.1 Europe Syndromic Multiplex Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Syndromic Multiplex Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Syndromic Multiplex Diagnostic Market Share by Type (2017-2028)
7.3 Europe Syndromic Multiplex Diagnostic Market Size by Application
7.3.1 Europe Syndromic Multiplex Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Syndromic Multiplex Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Syndromic Multiplex Diagnostic Market Share by Application (2017-2028)
7.4 Europe Syndromic Multiplex Diagnostic Market Size by Country
7.4.1 Europe Syndromic Multiplex Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Syndromic Multiplex Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type
8.2.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application
8.3.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Syndromic Multiplex Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region
8.4.1 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Syndromic Multiplex Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Syndromic Multiplex Diagnostic Market Size (2017-2028)
9.2 Latin America Syndromic Multiplex Diagnostic Market Size by Type
9.2.1 Latin America Syndromic Multiplex Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Syndromic Multiplex Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Syndromic Multiplex Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Syndromic Multiplex Diagnostic Market Size by Application
9.3.1 Latin America Syndromic Multiplex Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Syndromic Multiplex Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Syndromic Multiplex Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Syndromic Multiplex Diagnostic Market Size by Country
9.4.1 Latin America Syndromic Multiplex Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Syndromic Multiplex Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type
10.2.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application
10.3.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Syndromic Multiplex Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country
10.4.1 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Syndromic Multiplex Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Syndromic Multiplex Diagnostic Introduction
11.1.4 Abbott Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Hologic
11.2.1 Hologic Company Details
11.2.2 Hologic Business Overview
11.2.3 Hologic Syndromic Multiplex Diagnostic Introduction
11.2.4 Hologic Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.2.5 Hologic Recent Developments
11.3 Bosch
11.3.1 Bosch Company Details
11.3.2 Bosch Business Overview
11.3.3 Bosch Syndromic Multiplex Diagnostic Introduction
11.3.4 Bosch Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.3.5 Bosch Recent Developments
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Syndromic Multiplex Diagnostic Introduction
11.4.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.4.5 Danaher Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Syndromic Multiplex Diagnostic Introduction
11.5.4 Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Danaher
11.6.1 Danaher Company Details
11.6.2 Danaher Business Overview
11.6.3 Danaher Syndromic Multiplex Diagnostic Introduction
11.6.4 Danaher Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.6.5 Danaher Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Syndromic Multiplex Diagnostic Introduction
11.7.4 Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Syndromic Multiplex Diagnostic Introduction
11.8.4 Luminex Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.8.5 Luminex Recent Developments
11.9 bioMérieux
11.9.1 bioMérieux Company Details
11.9.2 bioMérieux Business Overview
11.9.3 bioMérieux Syndromic Multiplex Diagnostic Introduction
11.9.4 bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.9.5 bioMérieux Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Syndromic Multiplex Diagnostic Introduction
11.10.4 Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.10.5 Qiagen Recent Developments
11.11 Alveo Technologies
11.11.1 Alveo Technologies Company Details
11.11.2 Alveo Technologies Business Overview
11.11.3 Alveo Technologies Syndromic Multiplex Diagnostic Introduction
11.11.4 Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.11.5 Alveo Technologies Recent Developments
11.12 Mesa Biotech
11.12.1 Mesa Biotech Company Details
11.12.2 Mesa Biotech Business Overview
11.12.3 Mesa Biotech Syndromic Multiplex Diagnostic Introduction
11.12.4 Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.12.5 Mesa Biotech Recent Developments
11.13 Applied BioCode
11.13.1 Applied BioCode Company Details
11.13.2 Applied BioCode Business Overview
11.13.3 Applied BioCode Syndromic Multiplex Diagnostic Introduction
11.13.4 Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.13.5 Applied BioCode Recent Developments
11.14 Akonni Biosystems
11.14.1 Akonni Biosystems Company Details
11.14.2 Akonni Biosystems Business Overview
11.14.3 Akonni Biosystems Syndromic Multiplex Diagnostic Introduction
11.14.4 Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.14.5 Akonni Biosystems Recent Developments
11.15 Diagenode Diagnostics
11.15.1 Diagenode Diagnostics Company Details
11.15.2 Diagenode Diagnostics Business Overview
11.15.3 Diagenode Diagnostics Syndromic Multiplex Diagnostic Introduction
11.15.4 Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2017-2022)
11.15.5 Diagenode Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Gastrointestinal Syndromic Multiplex Diagnostic
Table 3. Key Players of Central Nervous System Syndromic Multiplex Diagnostic
Table 4. Key Players of Others
Table 5. Global Syndromic Multiplex Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Syndromic Multiplex Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Syndromic Multiplex Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Syndromic Multiplex Diagnostic Market Share by Region (2017-2022)
Table 9. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Syndromic Multiplex Diagnostic Market Share by Region (2023-2028)
Table 11. Syndromic Multiplex Diagnostic Market Trends
Table 12. Syndromic Multiplex Diagnostic Market Drivers
Table 13. Syndromic Multiplex Diagnostic Market Challenges
Table 14. Syndromic Multiplex Diagnostic Market Restraints
Table 15. Global Syndromic Multiplex Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Syndromic Multiplex Diagnostic Revenue Share by Players (2017-2022)
Table 17. Global Top Syndromic Multiplex Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Syndromic Multiplex Diagnostic as of 2021)
Table 18. Ranking of Global Top Syndromic Multiplex Diagnostic Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Syndromic Multiplex Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Syndromic Multiplex Diagnostic Product Solution and Service
Table 22. Date of Enter into Syndromic Multiplex Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Syndromic Multiplex Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2017-2022)
Table 26. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Syndromic Multiplex Diagnostic Revenue Market Share by Type (2023-2028)
Table 28. Global Syndromic Multiplex Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Syndromic Multiplex Diagnostic Revenue Share by Application (2017-2022)
Table 30. Global Syndromic Multiplex Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Syndromic Multiplex Diagnostic Revenue Share by Application (2023-2028)
Table 32. North America Syndromic Multiplex Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Syndromic Multiplex Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Syndromic Multiplex Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Syndromic Multiplex Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Syndromic Multiplex Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Syndromic Multiplex Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Syndromic Multiplex Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Syndromic Multiplex Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Syndromic Multiplex Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Syndromic Multiplex Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Syndromic Multiplex Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Syndromic Multiplex Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Syndromic Multiplex Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Syndromic Multiplex Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Syndromic Multiplex Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Syndromic Multiplex Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Syndromic Multiplex Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Syndromic Multiplex Diagnostic Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Syndromic Multiplex Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Syndromic Multiplex Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Syndromic Multiplex Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Syndromic Multiplex Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Syndromic Multiplex Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Syndromic Multiplex Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Syndromic Multiplex Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Syndromic Multiplex Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Syndromic Multiplex Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Syndromic Multiplex Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Syndromic Multiplex Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Syndromic Multiplex Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Syndromic Multiplex Diagnostic Product
Table 65. Abbott Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 66. Abbott Recent Developments
Table 67. Hologic Company Details
Table 68. Hologic Business Overview
Table 69. Hologic Syndromic Multiplex Diagnostic Product
Table 70. Hologic Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 71. Hologic Recent Developments
Table 72. Bosch Company Details
Table 73. Bosch Business Overview
Table 74. Bosch Syndromic Multiplex Diagnostic Product
Table 75. Bosch Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 76. Bosch Recent Developments
Table 77. Danaher Company Details
Table 78. Danaher Business Overview
Table 79. Danaher Syndromic Multiplex Diagnostic Product
Table 80. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 81. Danaher Recent Developments
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Syndromic Multiplex Diagnostic Product
Table 85. Johnson & Johnson Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 86. Johnson & Johnson Recent Developments
Table 87. Danaher Company Details
Table 88. Danaher Business Overview
Table 89. Danaher Syndromic Multiplex Diagnostic Product
Table 90. Danaher Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 91. Danaher Recent Developments
Table 92. Bio-Rad Laboratories Company Details
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Syndromic Multiplex Diagnostic Product
Table 95. Bio-Rad Laboratories Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 96. Bio-Rad Laboratories Recent Developments
Table 97. Luminex Company Details
Table 98. Luminex Business Overview
Table 99. Luminex Syndromic Multiplex Diagnostic Product
Table 100. Luminex Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 101. Luminex Recent Developments
Table 102. bioMérieux Company Details
Table 103. bioMérieux Business Overview
Table 104. bioMérieux Syndromic Multiplex Diagnostic Product
Table 105. bioMérieux Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 106. bioMérieux Recent Developments
Table 107. Qiagen Company Details
Table 108. Qiagen Business Overview
Table 109. Qiagen Syndromic Multiplex Diagnostic Product
Table 110. Qiagen Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 111. Qiagen Recent Developments
Table 112. Alveo Technologies Company Details
Table 113. Alveo Technologies Business Overview
Table 114. Alveo Technologies Syndromic Multiplex Diagnostic Product
Table 115. Alveo Technologies Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 116. Alveo Technologies Recent Developments
Table 117. Mesa Biotech Company Details
Table 118. Mesa Biotech Business Overview
Table 119. Mesa Biotech Syndromic Multiplex Diagnostic Product
Table 120. Mesa Biotech Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 121. Mesa Biotech Recent Developments
Table 122. Applied BioCode Company Details
Table 123. Applied BioCode Business Overview
Table 124. Applied BioCode Syndromic Multiplex Diagnostic Product
Table 125. Applied BioCode Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 126. Applied BioCode Recent Developments
Table 127. Akonni Biosystems Company Details
Table 128. Akonni Biosystems Business Overview
Table 129. Akonni Biosystems Syndromic Multiplex Diagnostic Product
Table 130. Akonni Biosystems Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 131. Akonni Biosystems Recent Developments
Table 132. Diagenode Diagnostics Company Details
Table 133. Diagenode Diagnostics Business Overview
Table 134. Diagenode Diagnostics Syndromic Multiplex Diagnostic Product
Table 135. Diagenode Diagnostics Revenue in Syndromic Multiplex Diagnostic Business (2017-2022) & (US$ Million)
Table 136. Diagenode Diagnostics Recent Developments
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Syndromic Multiplex Diagnostic Market Share by Type: 2021 VS 2028
Figure 2. Gastrointestinal Syndromic Multiplex Diagnostic Features
Figure 3. Central Nervous System Syndromic Multiplex Diagnostic Features
Figure 4. Others Features
Figure 5. Global Syndromic Multiplex Diagnostic Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Diagnostics Laboratories Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Syndromic Multiplex Diagnostic Report Years Considered
Figure 11. Global Syndromic Multiplex Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Syndromic Multiplex Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Syndromic Multiplex Diagnostic Market Share by Region: 2021 VS 2028
Figure 14. Global Syndromic Multiplex Diagnostic Market Share by Players in 2021
Figure 15. Global Top Syndromic Multiplex Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Syndromic Multiplex Diagnostic as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Syndromic Multiplex Diagnostic Revenue in 2021
Figure 17. North America Syndromic Multiplex Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Syndromic Multiplex Diagnostic Market Size Market Share by Type (2017-2028)
Figure 19. North America Syndromic Multiplex Diagnostic Market Size Market Share by Application (2017-2028)
Figure 20. North America Syndromic Multiplex Diagnostic Market Size Share by Country (2017-2028)
Figure 21. United States Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Syndromic Multiplex Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Syndromic Multiplex Diagnostic Market Size Market Share by Type (2017-2028)
Figure 25. Europe Syndromic Multiplex Diagnostic Market Size Market Share by Application (2017-2028)
Figure 26. Europe Syndromic Multiplex Diagnostic Market Size Share by Country (2017-2028)
Figure 27. Germany Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Syndromic Multiplex Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Syndromic Multiplex Diagnostic Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Syndromic Multiplex Diagnostic Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Syndromic Multiplex Diagnostic Market Size Share by Region (2017-2028)
Figure 37. China Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Syndromic Multiplex Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Syndromic Multiplex Diagnostic Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Syndromic Multiplex Diagnostic Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Syndromic Multiplex Diagnostic Market Size Share by Country (2017-2028)
Figure 47. Mexico Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Syndromic Multiplex Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Syndromic Multiplex Diagnostic Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Syndromic Multiplex Diagnostic Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Syndromic Multiplex Diagnostic Market Size Share by Country (2017-2028)
Figure 53. Turkey Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Syndromic Multiplex Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 57. Hologic Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 58. Bosch Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 59. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 60. Johnson & Johnson Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 61. Danaher Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 63. Luminex Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 64. bioMérieux Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 65. Qiagen Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 66. Alveo Technologies Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 67. Mesa Biotech Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 68. Applied BioCode Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 69. Akonni Biosystems Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 70. Diagenode Diagnostics Revenue Growth Rate in Syndromic Multiplex Diagnostic Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
